Enapotamab Vedotin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enapotamab Vedotin, covering 2023-01-05 to 2023-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]